Approval · Notice of Compliance 10468 · 2009
ERBITUX: Notice of Compliance 10468
Issued August 6, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10468
- Date
- August 6, 2009
- Company
- Imclone LlcBranchburg, New Jersey, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antineoplastic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ERBITUX | 02271249 | Marketed |
Medicinal ingredients
- CETUXIMAB 2 MG per ML